Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Medical Implant Market By Product Type (Orthopedic Implants, Cardiovascular Implants, Spinal Implant, Neurostimulators, Ophthalmic Implants, Dental Implants, Facial Implants, and Breast Implants) and Biomaterial Type (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials): Global Opportunity Analysis and Industry Forecast, 2020–2027

A00009
Pages: 360
Nov 2020 | 58225 Views
 
Author(s) : Sayali Shinde, Apoorva Srivastava , Onkar Sumant
Tables: 111
Charts: 113
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medical Implant Market

Request Now !

The medical implants market accounted for $85,389 million in 2019, and is expected to reach $147,464 million by 2027, registering a CAGR of 7.2% from 2020 to 2027.

Medical implant is an artificial device or tissue, which is used to replace damaged biological structures or enhance an existing biological structure. Medical implants are used in areas such as cardiovascular, orthopedic, neurological, and dental ailments. Some of the implants are made from skin, bone, or other body tissues, whereas some are made from metal, plastic, or ceramic materials. Medical implants can be permanent or temporary and can be removed when they are no longer required. Risks and complications associated with medical implantation are infection, surgical failure, and implant failure. 

Medical-Implant-Market-2020-2027

Get more information on this report : Request Sample Pages

Most markets are witnessing decline in growth rate, owing to the outbreak of COVID-19, including the medical implants market. In addition, the American College of Surgeons (ACS) has recently developed guidelines for triage of vascular surgery patients, suggesting that non-emergency peripheral vascular procedures such as endovascular therapy for claudication should be postponed. Moreover, in regions severely affected by COVID-19, vascular procedures have been reduced to life or limb salvaging cases, owing to new government directives or hospital guidelines. All these factors are anticipated to impact the medical implants market in the future.

Rise in aging population and increase in prevalence of chronic diseases are some of the major driving factors for the medical implants market. Aged people are more susceptible to chronic diseases such as cardiovascular diseases, orthopedic disorders, endovascular diseases, and dental disorders, thus being the major users of medical implants.  For instance, with the increasing aging population, the demand for tooth loss is expected to grow. According to the American Academy Of Implant Dentistry (AAID), about 3 million people in the U.S. currently have dental implants, and this number is expected to grow by 500,000 annually.

The growth of the global medical implants market is further driven by technological advancements in medical implants. Moreover, hike in disposable income, availability of better medical facilities, surge in number of cases with damaged limbs or organs caused by different accidents are the factors that play pivotal role in accelerating the growth of the medical implants market.

Furthermore, increase in awareness about the different types of medical implants among healthcare professionals boosts the medical implant market growth. In addition, initiatives from medical health insurance companies to support the critical health issues is facilitating the growth of the market, globally. Moreover, rise in government support to provide medical insurance coverage to downtrodden people in the society for their better health is fueling the demand for medical implants. However, high cost of treatment associated with medical implant and stringent approval process hamper the growth of the market.

Medical Implant Market
By Product

Your browser does not support the canvas element.

Cardiovascular Implants segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Medical Implant Market Segmentation

The global medical implants market is segmented into product type, biomaterial, and region. On the basis product type, the market is categorized into orthopedic implants, cardiovascular implants, spinal implant, neurostimulators, ophthalmic implants, dental implants, facial implants, and breast implants. By biomaterial type, it is fragmented into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and natural biomaterials. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

On the basis of product type, the orthopedic implants segment is expected to hold a major medical implants market share in the global market, 2019, and is anticipated to continue this trend throughout the forecast period, owing to rise in prevalence of osteoporosis among aging population and increase in physical illness such as obesity. In addition, by biomaterial, the metallic biomaterial segment dominated the global medical implants market, due to increase in R&D investments, rise in applications of biomaterials, surge in demand for plastic surgery, and favorable reimbursements scenario.

Medical Implant Market
By Biomaterial

Your browser does not support the canvas element.

Polymers Biomaterials Segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific medical implant market

Asia-Pacific expected to hold a significant share in the market and presents lucrative opportunities for key players operating in the medical implant market, owing to increase in population, increase in awareness among consumers about these devices, and availability of trained healthcare professionals. In addition, rise in healthcare expenditure and improvement in healthcare infrastructure are expected to propel the medical implants market growth in the region. 

The report provides comprehensive analysis of the key players operating in the medical implant market such as Medtronic Plc., Johnson and Johnson, Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive, Inc., Integra LifeSciences Holding Corporation, Institut Straumann AG, and Conmed Corporation.

Medical Implant Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 8.8% during 2020-2027.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
  • The medical implants market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • The key market players and their strategies have been analyzed to understand the competitive outlook of the market.

Key Market Segments

By Product Type

  • Orthopedic Implants
    • Reconstructive Joint Replacements
      • Knee Replacement Implants
      • Hip Replacement Implants
      • Extremities
    • Orthobiologics
    • Trauma & Craniomaxillofacial
  • Cardiovascular Implants
    • Pacing Devices
      • Cardiac Resynchronization Therapy Devices (CRTs)
        • CRT-P (CRT with pacemaker function)
        • CRT-D (CRT with pacemaker and ICD function)
      • Implantable Cardioverter Defibrillators (ICDs)
        • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
        • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • Implantable Cardiac Pacemakers (ICPs)
  • Stents
    • Coronary Stents
      • Drug-eluting Stents (DES)
      • Bare-metal Coronary Stents
      • Bioabsorbable Stents
    • Peripheral Stents
    • Iliac
    • Femoral–Popliteal
    • Renal
    • Carotid
  • Stent-related Implants
    • Synthetic Grafts
    • Vena Cava Filters
  • Structural Cardiac Implants
    • Mechanical Heart Valves
    • Implantable Ventricular-assist Devices
      • LVAD
      • RVAD
      • BIVAD
  • Spinal Implants
    • Spinal Fusion Implants
    • Spinal Bone Stimulators
    • Vertebral Compression Fracture (VCF) Devices
    • Motion Preservation Devices/Non-fusion Devices
  • Neurostimulators
    • Deep Brain Stimulation (DBS)
    • Sacral Nerve Stimulation (SNS)
    • Vagus Nerve Stimulation (VNS)
    • Spinal Cord Stimulation (SCS)
    • Other neurostimulators
  • Opthalmic Implants
    • Intraocular Lens
    • Glaucoma Implants
  • Dental Implants
    • Plate Form Dental Implants
    • Root Form Dental Implants
  • Facial Implants
  • Breast implants

By Biomaterial Type

  • Metallic Biomaterials 
  • Ceramic Biomaterials 
  • Polymers Biomaterials 
  • Natural Biomaterials

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Rest of Asia-Pacific
    • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Research methodology

1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Top player positioning

3.2.1.Top investment pockets

3.3.Key forces shaping medical implant industry/market

3.1.Market dynamics

3.1.1.Drivers

3.1.1.1.Growing elderly population and rise in prevalence of chronic diseases
3.1.1.2.Technological advancements in the field of medical implant
3.1.1.3.Global rise in acceptance of medical implant
3.1.1.4.Improvement of healthcare infrastructure in developing countries
3.1.1.5.Rising number of FDA approvals for performing clinical trials to benefit the market

3.1.2.Restraint

3.1.2.1.High cost of treatment associated with medical implant
3.1.2.2.Stringent approval process as these are highly specialized devices

3.1.3.Opportunity

3.1.3.1.Huge market opportunities in the APAC region and developing countries
3.1.3.2.Increasing awareness amongst patients and increasing preference for a better quality of life
3.1.3.3.Increase in development of minimally invasive and non-surgical procedures

3.1.4.Impact Analysis

3.1.COVID-19 impact on the medical implant market

CHAPTER 4:MEDICAL IMPLANTS MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.1.ORTHOPEDIC IMPLANTS

4.1.1.Key market trends, growth factors, and opportunities
4.1.2.Market size and forecast, by region
4.1.3.Market analysis, by country
4.1.4.Orthopedic Implants, By type

4.1.4.1.Market size and forecast
4.1.4.2.Reconstructive joint replacements
4.1.4.3.Market size and forecast
4.1.4.4.Reconstructive joint replacements, By type

4.1.4.4.1.Market size and forecast
4.1.4.4.2.Knee Replacement Implants
4.1.4.4.3.Hip Replacement Implants
4.1.4.4.4.Extremities

4.1.4.5.Orthobiologics
4.1.4.6.Market size and forecast
4.1.4.7.Trauma & Craniomaxillofacial
4.1.4.8.Market size and forecast

4.2.CARDIOVASCULAR IMPLANTS

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Cardiovascular implants, By type

4.2.4.1.Market size and forecast
4.2.4.2.Pacing Devices
4.2.4.3.Market size and forecast
4.2.4.4.Pacing devices, By type

4.2.4.4.1.Market size and forecast
4.2.4.4.2.Cardiac resynchronization therapy devices (CRTs), market size and forecast
4.2.4.4.3.Cardiac resynchronization therapy devices (CRTs), By type

4.2.4.4.3.1.Market size and forecast
4.2.4.4.3.2.CRT-P (CRT with pacemaker function)
4.2.4.4.3.3.CRT-D (CRT with pacemaker and ICD function)

4.2.4.4.4.Implantable Cardioverter Defibrillators (ICDs)
4.2.4.4.5.Implantable cardioverter defibrillators (ICDs), By type

4.2.4.4.5.1.Market size and forecast
4.2.4.4.5.2.Transvenous implantable cardioverter defibrillator (T-ICDs)
4.2.4.4.5.3.Subcutaneous implantable cardioverter defibrillator (S-ICDs)

4.2.4.4.6.Implantable Cardiac Pacemakers (ICPs)

4.2.4.5.Stents
4.2.4.6.Market size and forecast
4.2.4.7.Stents, By type

4.2.4.7.1.Market size and forecast
4.2.4.7.2.Coronary stents
4.2.4.7.3.Coronary stents, By type

4.2.4.7.3.1.Market size and forecast
4.2.4.7.3.2.Drug-eluting stents (DES)
4.2.4.7.3.3.Bare-metal coronary stents
4.2.4.7.3.4.Bioabsorbable stents

4.2.4.7.4.Peripheral stents
4.2.4.7.5.Peripheral stents, By type

4.2.4.7.5.1.Market size and forecast
4.2.4.7.5.2.Iliac
4.2.4.7.5.3.Femoral-Popliteal
4.2.4.7.5.4.Renal
4.2.4.7.5.5.Carotid

4.2.4.7.6.Stent-related Implants
4.2.4.7.7.Stent-related Implants, By type

4.2.4.7.7.1.Market size and forecast
4.2.4.7.7.2.Synthetic grafts
4.2.4.7.7.3.Vena cava filters

4.2.4.8.Structural Cardiac Implants
4.2.4.9.Market size and forecast
4.2.4.10.Structural cardiac implants, By type

4.2.4.10.1.Market size and forecast
4.2.4.10.2.Mechanical heart valves
4.2.4.10.3.Implantable ventricular-assist devices
4.2.4.10.4.Implantable ventricular-assist devices, By type

4.2.4.10.4.1.Market size and forecast

4.2.4.10.5.LVAD
4.2.4.10.6.RVAD
4.2.4.10.7.BIVAD

4.3.Spinal Implants

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Spinal Implants, By type

4.3.4.1.Market size and forecast
4.3.4.2.Spinal fusion implants
4.3.4.3.Market size and forecast
4.3.4.4.Spinal bone stimulators
4.3.4.5.Market size and forecast
4.3.4.6.Vertebral Compression Fracture (VCF) Devices
4.3.4.7.Market size and forecast
4.3.4.8.Motion preservation devices/non-fusion devices
4.3.4.9.Market size and forecast

4.4.Neurostimulators

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Neurostimulators, By type

4.4.4.1.Market size and forecast
4.4.4.2.Deep Brain Stimulation (DBS)
4.4.4.3.Market size and forecast
4.4.4.4.Sacral Nerve Stimulation (SNS)
4.4.4.5.Market size and forecast
4.4.4.6.Vagus Nerve Stimulation (VNS)
4.4.4.7.Market size and forecast
4.4.4.8.Spinal Cord Stimulation (SCS)
4.4.4.9.Market size and forecast
4.4.4.10.Other neurostimulators
4.4.4.11.Market size and forecast

4.5.Opthalmic Implants

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.Opthalmic Implants, By type

4.5.4.1.Market size and forecast
4.5.4.2.Intraocular Lens
4.5.4.3.Market size and forecast
4.5.4.4.Glaucoma Implants
4.5.4.5.Market size and forecast

4.6.Dental Implants

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
4.6.4.Dental implants, By type

4.6.4.1.Market size and forecast
4.6.4.2.Plate form dental implants
4.6.4.3.Market size and forecast
4.6.4.4.Root form dental implants
4.6.4.5.Market size and forecast

4.7.Facial Implants

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market analysis, by country

4.8.BREAST IMPLANTS

4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.3.Market analysis, by country

CHAPTER 5:MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Metallic Biomaterials 

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Ceramic biomaterials

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Polymers biomaterials

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Natural biomaterials

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

CHAPTER 6:MEDICAL IMPLANTS MARKET, BY REGION

6.1.Overview
Market size and forecast
6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.3.Market size and forecast, by product
6.2.4.Market size and forecast, by biomaterial type

6.2.4.1.U.S.
6.2.4.2.U.S. Market size and forecast, by product
6.2.4.3.U.S. Market size and forecast, by biomaterial type
6.2.4.4.Canada
6.2.4.5.Canada Market size and forecast, by product
6.2.4.6.Canada Market size and forecast, by biomaterial type
6.2.4.7.Mexico
6.2.4.8.Mexico market size and forecast, by product
6.2.4.9.Mexico market size and forecast, by biomaterial type

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.3.Market size and forecast, by product
6.3.4.Market size and forecast, by biomaterial type

6.3.4.1.Germany
6.3.4.2.Germany market size and forecast, by product
6.3.4.3.Germany market size and forecast, by biomaterial type
6.3.4.4.France

6.3.4.5.France market size and forecast, by product
6.3.4.6.France market size and forecast, by biomaterial type
6.3.4.7.UK
6.3.4.8.UK Market size and forecast, by product
6.3.4.9.UK Market size and forecast, by biomaterial type
6.3.4.10.Italy
6.3.4.11.Italy market size and forecast, by product
6.3.4.12.Italy market size and forecast, by biomaterial type
6.3.4.13.Spain
6.3.4.14.Spain market size and forecast, by product
6.3.4.15.Spain market size and forecast, by biomaterial type
6.3.4.16.Rest of Europe
6.3.4.17.Rest of Europe market size and forecast, by product
6.3.4.18.Rest of Europe market size and forecast, by biomaterial type

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.3.Market size and forecast, by product
6.4.4.Market size and forecast, by biomaterial type

6.4.4.1.Japan
6.4.4.2.Japan market size and forecast, by product
6.4.4.3.Japan market size and forecast, by biomaterial type
6.4.4.4.China
6.4.4.5.China market size and forecast, by product
6.4.4.6.China market size and forecast, by biomaterial type
6.4.4.7.India
6.4.4.8.India market size and forecast, by product
6.4.4.9.India market size and forecast, by biomaterial type
6.4.4.10.Australia
6.4.4.11.Australia market size and forecast, by product
6.4.4.12.Australia market size and forecast, by biomaterial type
6.4.4.13.South Korea
6.4.4.14.South Korea market size and forecast, by product
6.4.4.15.South Korea market size and forecast, by biomaterial type
6.4.4.16.Rest of Asia-Pacific
6.4.4.17.Rest of Asia-Pacific market size and forecast, by product
6.4.4.18.Rest of Asia-Pacific market size and forecast, by biomaterial type

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.3.Market size and forecast, by product
6.5.4.Market size and forecast, by biomaterial type

6.5.4.1.Brazil
6.5.4.2.Brazil market size and forecast, by product
6.5.4.3.Brazil market size and forecast, by biomaterial type
6.5.4.4.South Africa
6.5.4.5.South Africa market size and forecast, by product
6.5.4.6.South Africa market size and forecast, by biomaterial type
6.5.4.7.Saudi Arabia
6.5.4.8.Saudi Arabia market size and forecast, by product
6.5.4.9.Saudi Arabia market size and forecast, by biomaterial type
6.5.4.10.Rest of LAMEA
6.5.4.11.Rest of LAMEA market size and forecast, by product
6.5.4.12.Rest of LAMEA market size and forecast, by biomaterial type

CHAPTER 7:COMPANY PROFILES

7.1.Biotronik, Inc.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.1.Key strategic moves and developments

7.2.Boston Scientific Corporation

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance

7.3.CONMED Corporation

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.GLOBUS MEDICAL, INC.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.Institut Straumann AG

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.Integra LifeSciences Holdings Corporation

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance

7.7.JOHNSON & JOHNSON

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance

7.8.LivaNova PLC

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.Medtronic Plc.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.NUVASIVE, INC.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.MEDICAL IMPLANTS MARKET FOR ORTHOPEDIC IMPLANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.ORTHOPEDIC IMPANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 04.RECONSTRUCTIVE JOINT REPLACEMENTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.MEDICAL IMPLANTS MARKET FOR CARDIOVASCULAR IMPLANTS , BY REGION, 2019–2027 ($MILLION)
TABLE 06.CARDIOVASCULAR IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.PACING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRTS) MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 10.STENTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.CORONARY STENTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.PERIPHERAL STENTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 13.STENT-RELATED IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.STRUCTURAL CARDIAC IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 15.IMPLANTABLE VENTRICULAR-ASSIST DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.MEDICAL IMPLANTS MARKET FOR SPINAL IMPLANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 17.SPINAL IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 18.MEDICAL IMPLANTS MARKET FOR NEUROSTIMULATORS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.NEUROSTIMULATORS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 20.MEDICAL IMPLANTS MARKET FOR OPHTHALMIC IMPLANTS, BY REGION, 2019–2027 ($MILLION)
TABLE 21.OPTHALMIC IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 22.MEDICAL IMPLANT MARKET FOR DENTAL IMPLANT, BY REGION, 2019–2027 ($MILLION)
TABLE 23.DENTAL IMPLANTS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 24.FACIAL IMPLANTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.BREAST IMPLANT MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 26.GLOBAL MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 27.MEDICAL IMPLANTS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2019–2027 ($MILLION)
TABLE 28.MEDICAL IMPLANTS MARKET FOR CERAMIC BIOMATERIALS, BY REGION, 2019–2027 ($MILLION)
TABLE 29.MEDICAL IMPLANTS MARKET FOR POLYMERS BIOMATERIALS, BY REGION, 2019–2027 ($MILLION)
TABLE 30.MEDICAL IMPLANTS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2019–2027 ($MILLION)
TABLE 31.MEDICAL IMPLANTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 32.NORTH AMERICA MEDICAL IMPLANTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 33.NORTH AMERICA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 34.NORTH AMERICA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 35.U.S. MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 36.U.S. MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 37.CANADA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 38.CANADA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 39.MEXICO MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 40.MEXICO MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 41.EUROPE MEDICAL IMPLANTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.EUROPE MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 43.EUROPE MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 44.GERMANY MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 45.GERMANY MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 46.FRANCE MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 47.FRANCE MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 48.UK MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 49.UK MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 50.ITALY MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 51.ITALY MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 52.SPAIN MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 53.SPAIN MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 54.REST OF EUROPE MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 55.REST OF EUROPE MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 56.ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 57.ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 58.ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 59.JAPAN MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 60.JAPAN MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 61.CHINA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 62.CHINA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 63.INDIA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 64.INDIA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 65.AUSTRALIA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 66.AUSTRALIA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 67.SOUTH KOREA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 68.SOUTH KOREA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 71.LAMEA MEDICAL IMPLANTS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 72.LAMEA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.LAMEA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 74.BRAZIL MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 75.BRAZIL MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 76.SOUTH AFRICA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 77.SOUTH AFRICA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 78.SAUDI ARABIA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 79.SAUDI ARABIA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 80.REST OF LAMEA MEDICAL IMPLANTS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 81.REST OF LAMEA MEDICAL IMPLANTS MARKET, BY BIOMATERIAL TYPE, 2019–2027 ($MILLION)
TABLE 82.BIOTRONIK: COMPANY SNAPSHOT
TABLE 83.BIOTRONIK: OPERATING SEGMENTS
TABLE 84.BIOTRONIK:PRODUCT PORTFOLIO
TABLE 85.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 86.BOSTON: OPERATING SEGMENTS
TABLE 87.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 88.CONMED: COMPANY SNAPSHOT
TABLE 89.CONMED CORPORATION: PRODUCT SEGMENTS
TABLE 90.CONMED: PRODUCT PORTFOLIO
TABLE 91.GLOBUS MEDICAL.: COMPANY SNAPSHOT
TABLE 92.GLOBUS MEDICAL.: OPERATING SEGMENTS
TABLE 93.GLOBUS MEDICAL: PRODUCT PORTFOLIO
TABLE 94.STRAUMANN: COMPANY SNAPSHOT
TABLE 95.GLOBUS MEDICALTINGLOBUS MEDICAL: OPERATING SEGMENTS
TABLE 96.STRAUMANN: PRODUCT PORTFOLIO:
TABLE 97.INTEGRA: COMPANY SNAPSHOT
TABLE 98.INTEGRA: OPERATING SEGMENTS
TABLE 99.INTEGRA: PRODUCT PORTFOLIO
TABLE 100.J&J: COMPANY SNAPSHOT
TABLE 101.J&J: OPERATING SEGMENTS
TABLE 102.J&J: PRODUCT PORTFOLIO
TABLE 103.LIVANOVA: COMPANY SNAPSHOT
TABLE 104.LIVANOVA: OPERATING SEGMENTS
TABLE 105.LIVANOVA: PRODUCT PORTFOLIO
TABLE 106.MEDTRONIC: COMPANY SNAPSHOT
TABLE 107.MEDTRONIC: OPERATING SEGMENTS
TABLE 108.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 109.NUVASIVE: COMPANY SNAPSHOT
TABLE 110.NUVASIVE: OPERATING SEGMENTS
TABLE 111.NUVASIVE: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL MEDICAL IMPLANTS MARKETSEGMENTATION
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF RIVALRY
FIGURE 08.MODERATE THREAT OF NEW ENTRANT
FIGURE 09.IMPACT ANALYSIS, MEDICAL IMPLANTS MARKET
FIGURE 10.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR ORTHOPEDIC IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 11.RECONSTRUCTIVE JOINT REPLACEMENTS MARKET, 2019–2027 ($MILLION)
FIGURE 12.KNEE REPLACEMENT IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 13.HIP REPLACEMENT IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 14.EXTREMITIES MARKET, 2019–2027 ($MILLION)
FIGURE 15.ORTHOBIOLOGICS MARKET, 2019–2027 ($MILLION)
FIGURE 16.TRAUMA & CRANIOMAXILLOFACIAL  MARKET, 2019–2027 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR CARDIOVASCULAR IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 18.PACING DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 19.CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRTS) MARKET, 2019–2027 ($MILLION)
FIGURE 20.CRT-P (CRT WITH PACEMAKER FUNCTION) MARKET, 2019–2027 ($MILLION)
FIGURE 21.CRT-D (CRT WITH PACEMAKER AND ICD FUNCTION) MARKET, 2019–2027 ($MILLION)
FIGURE 22.IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) MARKET, 2019–2027 ($MILLION)
FIGURE 23.TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, 2019–2027 ($MILLION)
FIGURE 24.SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICDS) MARKET, 2019–2027 ($MILLION)
FIGURE 25.IMPLANTABLE CARDIAC PACEMAKERS (ICPS) MARKET, 2019–2027 ($MILLION)
FIGURE 26.STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 27.CORONARY STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 28.DRUG-ELUTING STENTS (DES) MARKET, 2019–2027 ($MILLION)
FIGURE 29.BARE-METAL CORONARY STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 30.BIOABSORBABLE STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 31.PERIPHERAL STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 32.ILIAC MARKET, 2019–2027 ($MILLION)
FIGURE 33.FEMORAL-POPLITEAL MARKET, 2019–2027 ($MILLION)
FIGURE 34.RENAL MARKET, 2019–2027 ($MILLION)
FIGURE 35.CAROTID MARKET, 2019–2027 ($MILLION)
FIGURE 36.STENT-RELATED IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 37.SYNTHETIC GRAFTS MARKET, 2019–2027 ($MILLION)
FIGURE 38.VENA CAVA FILTERS MARKET, 2019–2027 ($MILLION)
FIGURE 39.STRUCTURAL CARDIAC IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 40.MECHANICAL HEART VALVES MARKET, 2019–2027 ($MILLION)
FIGURE 41.IMPLANTABLE VENTRICULAR-ASSIST DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 42.LVAD MARKET, 2019–2027 ($MILLION)
FIGURE 43.RVAD MARKET, 2019–2027 ($MILLION)
FIGURE 44.BIVAD MARKET, 2019–2027 ($MILLION)
FIGURE 45.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR SPINAL IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 46.SPINAL FUSION IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 47.SPINAL BONE STIMULATORS MARKET, 2019–2027 ($MILLION)
FIGURE 48.VERTEBRAL COMPRESSION FRACTURE (VCF) DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 49.MOTION PRESERVATION DEVICES/NON-FUSION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 50.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR NEUROSTIMULATORS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 51.DEEP BRAIN STIMULATION (DBS) MARKET, 2019–2027 ($MILLION)
FIGURE 52.SACRAL NERVE STIMULATION MARKET, 2019–2027 ($MILLION)
FIGURE 53.VAGUS NERVE STIMULATION (VNS) MARKET, 2019–2027 ($MILLION)
FIGURE 54.SPINAL CORD STIMULATION (SCS) MARKET, 2019–2027 ($MILLION)
FIGURE 55.OTHER NEUROSTIMULATORS MARKET, 2019–2027 ($MILLION)
FIGURE 56.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR OPHTHALMIC IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 57.INTRAOCULAR LENS MARKET, 2019–2027 ($MILLION)
FIGURE 58.GLAUCOMA IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 59.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR DENTAL IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 60.PLATE FORM DENTAL IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 61.ROOT FORM DENTAL IMPLANTS MARKET, 2019–2027 ($MILLION)
FIGURE 62.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR FACIAL IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 63.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR BREAST IMPLANTS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 64.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 65.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR CERAMIC BIOMATERIALS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 66.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR POLYMERS BIOMATERIALS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 67.COMPARATIVE ANALYSIS OF MEDICAL IMPLANTS MARKET FOR NATURAL BIOMATERIALS, BY COUNTRY,  2019 & 2027 (%)
FIGURE 68.U.S. MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 69.CANADA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 70.MEXICO MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 71.GERMANY MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 72.FRANCE MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 73.UK MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 74.ITALY MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 75.SPAIN MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 76.REST OF EUROPE MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 77.JAPAN MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 78.CHINA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 79.INDIA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 80.AUSTRALIA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 81.SOUTH KOREA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 82.REST OF ASIA-PACIFIC MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 83.BRAZIL MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 84.SOUTH AFRICA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 85.SAUDI ARABIA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 86.REST OF LAMEA MEDICAL IMPLANT MARKET, 2019–2027 ($MILLION)
FIGURE 87.BOSTON SCIENTIFIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 88.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 89.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2019(%)
FIGURE 90.CONMED: NET SALES, 2017–2019 ($MILLION)
FIGURE 91.CONMED: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 92.CONMED: REVENUE SHARE BY REGIONS, 2019 (%)
FIGURE 93.GLOBUS MEDICAL: NET SALES, 2017–2019 ($MILLION)
FIGURE 94.GLOBUS MEDICAL: REVENUE SHARE BY SEGMENT, 2019(%)
FIGURE 95.GLOBUS MEDICAL: REVENUE SHARE BY REGION, 2019(%)
FIGURE 96.STRAUMANN: NET SALES, 2017–2019 ($MILLION)
FIGURE 97.STRAUMANN: REVENUE SHARE BY SEGMENTS, 2019(%)
FIGURE 98.STRAUMANN: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 99.INTEGRA: NET SALES, 2018–2019 ($MILLION)
FIGURE 100.INTEGRA REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 101.INTEGRA: REVENUE SHARE BY REGIONS, 2019 (%)
FIGURE 102.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 103.J&J: REVENUE SHARE BY SEGMENT, 2019(%)
FIGURE 104.J&J: REVENUE SHARE BY REGION, 2019(%)
FIGURE 105.LIVANOVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 106.LIVANOVA: REVENUE SHARE BY SEGMENTS, 2019(%)
FIGURE 107.LIVANOVA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 108.MEDTRONIC PLC: NET SALES, 2017–2019 ($MILLION)
FIGURE 109.MEDTRONIC: REVENUE SHARE BY SEGMENTS, 2019(%)
FIGURE 110.MEDTRONIC: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 111.NET SALES, 2017–2019 ($MILLION)
FIGURE 112.NUVASIVE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 113.NUVASIVE: REVENUE SHARE BY REGION, 2019 (%)

 
 

The medical implant market has piqued the interest of healthcare providers due to several benefits offered by these devices to monitor and treat clinical disorders. Furthermore, the adoption of medical implants such as cardiac, orthopedic, dental, and breast implants is anticipated to witness significant increase with rise in prevalence of chronic diseases and rapidly aging population. Furthermore, remarkable technological advancements have been witnessed in medical implants to provide advanced treatment options for the management of diseases. 

As the market is saturated with steady growth rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to the key players.

The growth of the global market is further driven by surge in incidence of chronic diseases, rise in acceptance of medical implants, and improvement of healthcare infrastructure in emerging nations. However, high cost of treatment associated with medical implants, reimbursement issues, and stringent regulatory policies for the approval of these implants are expected to restrain the market growth. Currently, orthopedic implants is the largest segment of medical implant market. Increase in obesity and rise in incidence of osteoporosis-related fracture among all age groups are likely maintain the need for orthopedic interventions. In addition, emerging markets are gaining more importance for majority of medical implant manufacturers and distributors. A rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. North America is expected to dominate the global medical implant market during the forecast period, followed by Europe.

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Medical Implant Market is $1,47,463.5 million in 2019.

A. The forcast period for Medical Implant Market is 2020 to 2027

A. The market value of Medical Implant Market in 2020 is $90,674.2 million.

A. The base year is 2019 in Medical Implant Market

A. Top companies such as,Medtronic plc, Johnson and Johnson, Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive, Inc., Integra LifeSciences Holding Corporation, Institut Straumann AG and Conmed Corporation held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in all region

A. orthopedic implants segment is the most influencing segment owing to the stressful hyperactive lifestyle, unhealthy food habits, growing number of aging population and advancement in medical technologies.

A. The major factor that fuels the growth of the Medical Implant Market includes Increasing prevalence of chronic diseases and growing aging population are some of the major driving factors for the global medical implants market. Moreover, advancements in medical implants and rising awareness about artificial implants are also supporting the growth of the global medical implants market.

A. Medical implants are devices or tissues that are placed inside or on the surface of the body. Many implants are prosthetics, intended to replace missing body parts. Other implants deliver medication, monitor body functions, or provide support to organs and tissues

A. Medical implants are devices or tissues that are placed inside or on the surface of the body. Many implants are prosthetics, intended to replace missing body parts.

A. No, there is no value chain analysis provided in the Medical Implant Market report.

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Medical Implant Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers